tiprankstipranks
Trending News
More News >
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market

Xeris Pharmaceuticals (XERS) Income Statement

Compare
1,068 Followers

Xeris Pharmaceuticals Income Statement

Last quarter (Q3 2025), Xeris Pharmaceuticals's total revenue was $74.38M, an increase of 37.06% from the same quarter last year. In Q3, Xeris Pharmaceuticals's net income was $621.00K. See Xeris Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 23Dec 23Dec 23
Total Revenue
$ 203.07M$ 163.91M$ 163.91M$ 163.91M$ 163.91M
Gross Profit
$ 166.24M$ 135.27M$ 135.27M$ 135.27M$ 135.27M
Operating Expenses
$ 199.88M$ 179.28M$ 179.28M$ 179.28M$ 179.28M
Depreciation and Amortization
$ 12.63M$ 13.16M$ 13.16M$ 13.16M$ 13.16M
EBITDA
$ -13.99M$ -23.73M$ -23.73M$ -23.73M$ -23.73M
Operating Income
$ -33.65M$ -44.01M$ -44.01M$ -44.01M$ -44.01M
Other Income/Expenses
$ -23.46M$ -19.49M$ -19.49M$ -19.49M$ -19.49M
Pretax Income
$ -57.10M$ -63.50M$ -63.50M$ -63.50M$ -63.50M
Net Income
$ -54.84M$ -62.26M$ -62.26M$ -62.26M$ -62.26M
Per Share Metrics
Basic EPS
$ -0.37$ -0.45$ -0.45$ -0.45$ -0.45
Diluted EPS
$ -0.37$ -0.45$ -0.45$ -0.45$ -0.45
Weighted Average Shares Outstanding
146.77M 137.67M 137.67M 137.67M 137.67M
Weighted Average Shares Outstanding (Diluted)
146.77M 137.67M 137.67M 137.67M 137.67M
Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History